May 7, 2018 / 12:32 PM / 19 days ago

BRIEF-Amneal Initiates Phase 3 Study

May 7 (Reuters) - Amneal:

* AMNEAL INITIATES PHASE 3 STUDY FOR IPX203, AN INVESTIGATIONAL EXTENDED-RELEASE FORMULATION OF CARBIDOPA-LEVODOPA (CD-LD) IN ADVANCED PARKINSON’S DISEASE PATIENTS Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below